GET DAILY SIGNALSNatural Health Trends (NHTC) Shows Narrowing Losses in Mixed Q3 2026 Results
Key Takeaways
- Natural Health Trends (NHTC) reported third quarter 2026 revenue of $7.6 million, flat versus the prior quarter but down 20% from $9.5 million a year earlier.
- Net loss narrowed to $232,000, or $0.03 per diluted share, improving from $451,000, or $0.05 per share, in the second quarter of 2026.
- Operating loss fell 57% sequentially to $277,000, reflecting the ongoing impact of the company's restructuring and cost-reduction program.
- Active Members rose to 27,040 from 26,000 at the end of June, a sequential rebound even as the member base remains below year-ago levels.
- The Board of Directors authorized additional share repurchases, with roughly $15.8 million remaining available under the existing program.
Why These Results Matter
Natural Health Trends Corp. (NHTC) operates as an international direct-selling and e-commerce business focused on premium personal care, wellness, and quality-of-life products under the NHT Global brand. Its performance draws attention because the company remains heavily exposed to Hong Kong and China, where cautious consumer spending and regulatory questions have weighed on activity for several quarters now. The third-quarter 2026 update provides a useful checkpoint on whether restructuring steps are helping narrow losses, whether the Active Member count can hold steady, and whether buybacks and dividends can continue without straining a softer revenue base.
Quarterly Numbers in Detail
For the three months ended September 30, 2026, NHTC posted revenue of $7.6 million. That figure matched the second quarter of 2026 but represented a 20% drop from $9.5 million in the third quarter of 2025. Management linked most of the year-over-year decline to new incentives and lower-priced packages designed to improve product accessibility.
The operating loss improved to $277,000 from $643,000 in the prior quarter and $495,000 a year earlier. Net loss came in at $232,000, or $0.03 per diluted share, better than the $451,000 ($0.05 per share) reported in the second quarter of 2026 and the $431,000 ($0.04 per share) in the third quarter of 2025. Gross profit margin reached 74.2%, while Active Members increased sequentially to 27,040 at the end of September from 26,000 at the end of June. I also checked comparable names in the space using Tickeron’s AI Screener to put these metrics in context.
Over the first nine months of 2026, revenue totaled $24.4 million, down 19% from $30.0 million in the same period of 2025. The net loss widened to $837,000, or $0.09 per diluted share, from $294,000, or $0.03 per diluted share, a year earlier. Cash, cash equivalents, and marketable securities stood at $17.6 million at quarter end.
Market Reaction and Sentiment
Heading into the release, investor views on NHTC had stayed cautious amid ongoing softness in the core China and Hong Kong markets and a still-shrinking Active Member base over the past year. The latest results present a mixed signal: revenue stayed under pressure year over year, yet the sequential stabilization in the top line, the rebound in Active Members, and the sizable narrowing of the operating loss suggest cost controls are starting to work. Management highlighted a 57% sequential reduction in the operating loss plus roughly $1.1 million in year-to-date restructuring savings, elements that should influence how the market assesses progress toward a steadier cost structure.
What to Watch Going Forward
Looking ahead, the focus will be on whether the sequential stabilization in revenue and Active Members can carry into the fourth quarter and beyond. New product launches, including a joint-health supplement and a traditional Chinese medicine offering for the China market, plus an AI-powered marketing app, are positioned as ways to re-engage members and support demand.
Cost trends will remain central. The restructuring program is expected to generate further savings in the second half of 2026, and investors will track whether gross margins hold steady amid the promotional pricing that contributed to the revenue decline. On the balance sheet, the drop in cash and marketable securities—partly tied to share repurchases, dividends, and operating cash use—deserves attention alongside the Board’s authorization of additional buybacks.
Broader conditions in China and Hong Kong will continue to influence outcomes given the region’s outsized role in the business. Consumer sentiment, regulatory shifts, and member engagement levels will serve as important indicators of whether NHTC can eventually return to revenue growth.
Exploring AI Tools for Stock Analysis
When reviewing names in the consumer wellness space, I often rely on Tickeron’s AI Screener to quickly surface comparable ideas and emerging patterns across the sector. The tool lets users filter by technical patterns, fundamentals, volatility, and AI-driven signals, which helps surface potential opportunities more efficiently than manual methods. For investors following companies like this one, it can highlight peers and trends worth monitoring alongside the core fundamentals.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NHTC's Indicator enters downward trend
The Aroon Indicator for NHTC entered a downward trend on October 27, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 164 similar instances where the Aroon Indicator formed such a pattern. In 112 of the 164 cases the stock moved lower. This puts the odds of a downward move at 68%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NHTC as a result. In 64 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NHTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NHTC's RSI Oscillator exited the oversold zone, 15 of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for NHTC just turned positive on October 08, 2026. Looking at past instances where NHTC's MACD turned positive, the stock continued to rise in 29 of 41 cases over the following month. The odds of a continued upward trend are 71%.
Following a +14.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where NHTC advanced for three days, in 212 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
NHTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.485) is normal, around the industry mean (22.666). P/E Ratio (-5.729) is within average values for comparable stocks, (9.403). Projected Growth (PEG Ratio) (0.330) is also within normal values, averaging (1.774). NHTC's Dividend Yield (0.465) is considerably higher than the industry average of (0.033). P/S Ratio (0.436) is also within normal values, averaging (1.321).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. NHTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NHTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of natural health products
Industry InternetRetail
Advertisement